In May 2021, the Centers for Medicare and Medicaid Services (CMS) Quality Measures Voting Members unanimously recommended the addition of colorectal cancer (CRC) screening to the CMS Medicaid Adult Core Set of Quality Measures for adoption in 2022. However, CMS has the latitude to reject recommendations
from the Voting Members. The proposed CMS Medicaid CRC screening quality measure should be supported because it is actionable, has alignment with other metrics, is appropriate, is feasible, and will promote equity for all people insured through CMS.
Trending
- 43% Lower Mortality Seen in Colorectal Screening Participants (HCP Live)
- BioNTech halts mRNA colorectal cancer vaccine trial after safety review (Reuters)
- Microdroplets may reduce colorectal tumor growth at potentially lower cost (Medical Xpress)
- What it takes to build a gut-health service line (GI & Hepatology News)
- Weight Down, Steps Down: The GLP-1 Catch (Medscape)
- Pediatric Gastroenterology Faces AI Reality Check (Medscape)
- Ayble Health Joins Amazon’s Health Benefits Connector to expand Virtual GI Care Access to Millions of Americans (PR Newswire)
- Guardant Health’s Shield Blood Test Covered by Carelon Health Services for Colorectal Cancer Screening (Guardant Health)
